Processing of tumor necrosis factor by the membrane-bound TNF-α-converting enzyme, but not its truncated soluble form

European Journal of Biochemistry

Volumn 268, Issue 7, 2001, Pages 2074-2082

  Itai, Toshimitsu ^a,b   Tanaka, Masato ^a   Nagata, Shigekazu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Nihon Schering   (Japan)

Author keywords

ADAM family protease; Fas ligand; Shedding; TACE; TNF

Indexed keywords

FAS LIGAND; FAS LIGAND SECRETASE; ISOENZYME; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENZYME ACTIVE SITE; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION;

ADAM PROTEINS; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; PROTEIN CONFORMATION; PROTEIN PRECURSORS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034844231     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.02085.x     Document Type: Article

References (32)

1. The transmembrane form of the tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
2. Down-regulation of Fas ligand by shedding
3. Soluble cytokine receptors
4. Processing of tumor necrosis factor-α precursor by metalloproteinases
5. Regulation of tumor necrosis factor-α processing by a metalloproteinase inhibitor
6. Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing
7. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
8. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
9. Fas ligand in human serum
10. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells
11. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
12. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor α
13. Pro-tumor necrosis factor-α processing activity is tightly controlled by a component that does not affect Notch processing
14. An essential role for ectodomain shedding in mammalian development
15. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNFa and Notch
16. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain
17. A novel, secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo
18. A metalloprotease-disintegrin participating in myoblast fusion
19. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin
20. Myeloid-specific transcriptional activation by murine myeloid zinc finger protein-2
21. Expression of the functional soluble form of human Fas ligand in activated lymphocytes
22. Purification of ADAM 10 from bovine spleen as a TNFα convertase
23. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme
24. Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme
25. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain
26. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the alzheimer amyloid protein precursor
27. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
28. Evidence for an interaction of the metalloprotease-disintegrin tumor necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2β
29. A dominant negative form of TNF-α converting enzyme inhibits proTNF and TNFRII secretion
30. Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-α processing
31. The importance of shedding of membrane proteins for cytokine biology
32. The metalloproteinase matrilysin proteo-lytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis